Skip to content

Marketstatics

Menu
  • Home
  • About Us
  • Contact Us
Menu

Parkinson’s Levodopa Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Parkinson’s Levodopa Market Size and Forecast The global Levodopa market, a mainstay treatment for Parkinson’s disease (PD), was valued at $1,655.4 million in 2022. Levodopa, often combined with a decarboxylase inhibitor, remains…

ALS Riluzole Generics Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

ALS Riluzole Generics Market Size and Forecast The Riluzole generics market, primarily serving Amyotrophic Lateral Sclerosis (ALS) patients, is characterized by stability and high volume consumption. Although the branded Rilutek has faced…

PAH Endothelin Receptor Antagonists Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

PAH Endothelin Receptor Antagonists Market Size and Forecast The Pulmonary Arterial Hypertension (PAH) Endothelin Receptor Antagonists (ERAs) market is a critical segment of the cardiovascular therapeutics landscape. These drugs, including bosentan, ambrisentan,…

CFTR Modulators Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

CFTR Modulators Market Size and Forecast The CFTR Modulators market is the dominant segment within the broader cystic fibrosis (CF) therapeutics market, driven by the effectiveness of these therapies in addressing the…

Hemophilia Non-Factor Therapies Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Hemophilia Non-Factor Therapies Market Size and Forecast The Non-Factor Therapies segment is rapidly transforming the hemophilia treatment landscape, moving away from traditional factor replacement. Although it is a sub-segment of the total…

Hemophilia Factor VIII Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Hemophilia Factor VIII Market Size and Forecast The Hemophilia Factor VIII market, primarily focused on treating Hemophilia A, constitutes the largest share of the overall hemophilia treatment market. In 2024, the total…

Ulcerative Colitis Vedolizumab-like Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Ulcerative Colitis (UC) Vedolizumab-like Market Size and Forecast The market segment focusing on Vedolizumab-like therapies for Ulcerative Colitis, which target the α4β7 integrin, represents a critical and high-value area within inflammatory bowel…

Crohn’s Disease Anti-TNFs Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Crohn’s Disease Anti-TNFs Market Size and Forecast The market for Anti-Tumor Necrosis Factor (Anti-TNF) drugs in Crohn’s Disease (CD) represents a major segment of the broader Inflammatory Bowel Disease (IBD) therapeutics landscape….

Psoriatic Arthritis Biologics Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Psoriatic Arthritis Biologics Market Size and Forecast The Psoriatic Arthritis (PsA) Biologics Market is a significant segment within the broader PsA treatment landscape. The overall Psoriatic Arthritis Treatment Market was valued at…

Rheumatoid Arthritis JAK Inhibitors Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Rheumatoid Arthritis JAK Inhibitors Market Size and Forecast The global Janus Kinase (JAK) Inhibitors market, a critical segment in treating rheumatoid arthritis and other autoimmune diseases, was valued at approximately USD 18.7…

Posts pagination

Previous 1 … 85 86 87 … 101 Next

Categories

  • Healthcare
  • Pharmaceutical
  • Uncategorized
©2025 Marketstatics | Design: Newspaperly WordPress Theme